Introducing the Novel Endotracheal Tube System (NETS), a pioneering advancement set to redefine airway management during emergencies. Engineered to overcome the limitations of conventional Endotracheal Tubes (ET), NETS reshapes the approach to emergency intubation. With its innovative design and operational capabilities, NETS marks a transformative leap in airway management technology, offering heightened success rates and enhanced efficacy in both civilian and combat emergency scenarios.

This family of devices empowers frontline healthcare providers with cutting-edge solutions to combat airway obstructions in high-pressure environments. With each device tailored to specific needs and scenarios, the Suction Device Family ensures rapid and effective treatment, ultimately saving lives on the battlefield and beyond.

Introducing the Fiberoptic Microneedle Device (FMD), an innovative breakthrough driving the forefront of cancer treatment advancements. Engineered to redefine Plasmonic Photothermal Therapy (PPTT), FMD presents a game-changing strategy in battling pancreatic cancer, a condition marked by its challenging treatment landscape.

Introducing VOPS, the innovative Oxygenating Perfusion System engineered for organ preservation, primarily targeting kidneys for transplantation. Unlike traditional methods, VOPS enhances organ viability by oxygenating perfusion fluid without electricity, utilizing compressed oxygen for cyclic fluid pumping. Rigorous testing ensures optimal perfusion pressures and flow rates, offering a versatile and efficient solution that could expand the donor pool and improve transplantation outcomes.

The BV system generates 3D models of the inner surface of a bladder detecting abnormalities using computer vision and machine learning techniques.

Introducing a groundbreaking project in drug delivery technology – the Polymeric Device for Localized and Controlled Drug Delivery. Leveraging a 12-bead polymer injection mold, this innovative device streamlines the manufacturing process, ensuring precise ratios of Rhodamine B to PCL and PLA. This project lays the foundation for the development of implantable polymeric devices, offering a promising avenue for controlled drug delivery in chemotherapeutic treatments.